BCAB vs NTRS · $5.9M cap vs P/E 18, rev $8.09B
Bioatla Inc (BCAB) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported NTRS revenue for 2025-12-31 was $8.09B. Net income was $1.74B. Revenue was down 2.5% from 2024-12-31 to 2025-12-31. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
BCAB currently screens at market cap $5.9M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the BCAB and NTRS stock pages for the full models.
Not investment advice.